Skip to main content
. Author manuscript; available in PMC: 2019 Mar 1.
Published in final edited form as: Gynecol Oncol. 2018 Jan 12;148(3):480–484. doi: 10.1016/j.ygyno.2018.01.002

Table 3.

Odds of undergoing MIS versus open surgery



OR 95% CI P

Age at diagnosis (years)
Race
1.00 0.98, 1.02 0.87
White REF REF
Other / unknown 0.74 0.03– 20.31 0.46
Comorbid conditions
No comorbidities REF REF
1 comorbidity 0.79 0.14– 4.40 0.61
2 or more comorbidities 0.57 0.12– 2.62 0.25
Uterine size (cm)
<12 cm REF REF
12+ cm 0.17 0.03– 0.90 0.04
Unknown 1.19 0.43– 3.29 0.55
Pre-op histology
Non-invasive 2.60 0.22– 30.93 0.34
Endometrioid, grade 1 or 2 REF REF
Endometrioid, grade 3 0.65 0.27– 1.56 0.25
Clear cell or serous 0.71 0.26– 1.98 0.41
Other or unknown 0.47 0.18– 1.20 0.09
Pre-op stage
Stage I REF REF
Stage II 0.19 0.03– 1.19 0.06
Stage III 0.16 0.05– 0.49 0.01
Stage IV 0.07 0.02– 0.22 <0.01
Unknown 0.16 0.01– 2.88  0.09

Note: OR, odds ratio; CI, confidence interval; P, p-value corresponding to odds ratios. Mixed logistic regression model to evaluate selected factors that may be associated with undergoing MIS versus open surgery. Clinical site was a random effect; fixed effects (covariates) are shown in the table.